The focus of this paper is centred on measurement of blood flow in deep tissues with diffusing near-infrared (NIR) light. The paper is not intended as a comprehensive review; rather, we aim to provide a self-contained and personal perspective of the field using examples from our laboratory. The reader will gain insight about fundamental ideas that underpin the method, appreciation for the importance of measuring deep tissue blood flow and specific knowledge about how this general experimental approach can have an impact in clinical and pre-clinical contexts. Interested readers are encouraged to consult primary papers for more detail, as well as useful reviews [
1–
4] and references therein.
The diffuse light correlation techniques are built upon dynamic light-scattering concepts. The original ‘dynamic light scattering’ or ‘quasi-elastic light scattering’ techniques [
5–
8] recorded temporal fluctuations of light intensity scattered from a sample in order to learn about the motions of sample constituents, e.g. the Brownian dynamics of suspended colloidal particles or macromolecules. In typical single-scattering measurements, illuminated particles re-radiate incident light into many directions and the re-radiated light travelling along one direction is detected; when particles move, the relative phases of the collected re-radiated signals will vary and the detected light intensity fluctuates. Typically, when particles move through distances of the order of the wavelength of light, the collected signals are observed to fluctuate significantly. Information about these particle motions is derived from the scattered light electric field temporal autocorrelation function (or its Fourier transform).
The simple dynamic light-scattering method does not work when samples become turbid and incident light fields are multiply scattered. In practice, one can carry out the same temporal autocorrelation function measurements described above; however, inversion of correlation function data to recover quantitative information about scatterer motion is non-trivial in the multiple-scattering limit. Thus, direct application of the method to biological tissue is challenging.
Of course, similar challenges were faced by researchers aiming to carry out absorption spectroscopy of tissue, and these challenges were surmounted by modelling light transport through tissue as a diffusion problem. The diffusion approximation enabled experimenters to quantitatively understand the trajectory of light through tissue and then to ‘effectively reset’ the pathlengths employed in the traditional absorption spectroscopy measurement to new, tissue-scattering-dependent values. In a similar spirit, one can envision the electric field temporal autocorrelation function propagating through tissue, scattering from small volume elements within the sample and then propagating ballistically, then scattering again, etc., all in a random manner as the photons travel from one side of the tissue sample to a tissue surface (
a). A key steady-state mathematical equation governing the transport of electric field temporal autocorrelation through tissue is given below, i.e. the correlation diffusion equation [
9,
10]
Here,
G1(
r,
t)=
E*(
r,
t)
E(
r,
t+
τ)

is the unnormalized temporal electric field (
E(
r,
t)) autocorrelation function in the medium at position
r and time
t;
τ is the autocorrelation function time delay, and the brackets represent time and/or ensemble averages.
D![[congruent with]](/corehtml/pmc/pmcents/cong.gif)
1/(3
μ′
s) is the light diffusion coefficient in the medium;
μa is the absorption coefficient;
μ′
s is the reduced scattering coefficient (i.e. the inverse of the photon random walk step-length);
v is the speed of light in the medium, and
S(
r,
t) represents the light source.
The primary new features of the correlation diffusion equation compared with the conventional steady-state light diffusion equation (obtained from equation (
1.1) by letting the autocorrelation time,
τ, approach zero) are associated with particle motion:
α represents the fraction of photon-scattering events that occur from moving particles in the medium (e.g. red blood cells; RBCs);

Δ
r2(
τ)

is the mean-square particle displacement in time
τ (i.e. in tissue, the mean-square displacement factor could characterize the motions of RBCs in the tissue vasculature);
k0=2
π/
λ is the wavenumber of the light diffusing through the medium. Diffuse correlation spectroscopy (DCS) refers to the measurement of the diffusing temporal field autocorrelation function to obtain information about tissue dynamics. Equation (
1.1) is essentially a differential equation formulation of diffusing wave spectroscopy (DWS) [
11–
13], a technique developed earlier in the soft condensed matter community for studies of a variety of highly scattering complex fluids. DCS, as formulated above, is better suited than DWS (which essentially dealt with homogeneous turbid media) for handling point sources, heterogeneous media and as a starting formulation for correlation tomography in tissue.
As is the case for traditional dynamic light scattering, the
intensity autocorrelation function is usually measured by the experimenter, rather than the
field correlation function. The Siegert relation [
14] links these two correlation functions. It can be used to relate measurements of the intensity autocorrelation function to the theory for the electric field autocorrelation function, without direct measurement of phase information,
Here,
g1(
τ) and
g2(
τ) are the normalized autocorrelation functions for the electric field and intensity, respectively;
β is a coherence factor, which is mainly determined by the optical detection system, and it should be close to unity for an ideal experimental set-up and is often one-half in our measurements. Typically, best fits to either
g1(
τ) or
g2(
τ) are employed to derive a best estimate for the dynamical tissue factor,
α
Δ
r2(
τ)

.
The precise physiological origin of the factor,
α
Δ
r2(
τ)

, is not well understood. Much of the experimental evidence suggests that DCS, like near-infrared spectroscopy (NIRS, also called diffuse optical spectroscopy; DOS), is most sensitive to the physiology in the
microvasculature (i.e. capillaries, arterioles and venules). In fact, DCS shares many of the light penetration and modelling advantages of NIRS, but it provides a qualitatively different physiological signal. In NIRS, the signal is related to the haemoglobin concentration changes via optical absorption [
1,
15–
17]. By contrast, the DCS signal is due to the motion of scatterers in the tissue (i.e. RBCs); therefore, DCS provides a rather direct measure of blood flow. Although no significant cross-talk between NIRS and DCS has been observed, large changes in the blood volume (proportional to the sum of oxy- and deoxyhaemoglobin concentrations) will change the fraction of photon-scattering events,
α, therefore affecting the product,
α
Δ
r2(
τ)

. Such effects will be small and can be accounted for by independent NIRS/DOS measurements. For the mean-square particle displacement, in practice, the Brownian model,

Δ
r2(
τ)

=6
DBτ, fits the observed correlation decay curves fairly well over a wide range of tissue types and source–detector separations, including rat brain [
18–
22]; mouse tumours [
23–
26]; piglet brain [
27]; and human skeletal muscle [
28–
32], human tumours [
33–
39] and human brain [
40–
48] (
c). Here,
DB is an
effective diffusion coefficient that is a few orders of magnitude larger than the traditional thermal Brownian diffusion coefficient of cells in blood given by the Einstein–Smoluchowski relation [
49]. Use of the Brownian model is hardly satisfying. In fact, RBCs in the microvasculature do not move purely ballistically or diffusively; they experience position-dependent shear stresses and hydrodynamic interactions, and they roll, tumble and translate through the vasculature. The Brownian model provides a convenient approximation for data fitting and for defining a blood flow index (BFI
αDb) from the DCS measurement. The BFI is not a measure of absolute blood flow in the strict sense (e.g. it has the wrong units), but the relative change in BFI (i.e. rBFI) has been repeatedly shown () to be a quantitative measure of relative changes in blood flow (rBF) [
1,
3,
22,
27,
29,
46].
| Table 1.All in vivo DCS validation studies published to date. ASL-MRI, arterial spin-labelled MRI; PDT, photodynamic therapy. |
The complete details of a typical DCS experimental set-up can be found elsewhere [
2–
4]. Briefly, a narrowband continuous wave (CW) diode laser in the NIR range with long coherence length (i.e. greater than 20

m) is used as the light source. The light beam is delivered to the tissue through an optical fibre, with an output power of approximately 10–25

mW. The light-intensity fluctuations within a single speckle area are detected using a single-mode fibre and a fast single photon-counting device (e.g. an avalanche photo-diode). Finally, an autocorrelator takes the detector output and uses photon arrival times to compute the light-intensity temporal autocorrelation function. The integration time for generating a reliable curve depends on source–detector separation, etc., but typically varies from 1 to 3

s. Since single-mode fibres are employed for detection, the detection area is small and achieving a high signal-to-noise ratio (SNR) is challenging at the largest source–detector separations. Besides the laser power and the integration time, the SNR also depends on the source–detector distance,
ρ. For small animals such as mice and rats, in which 0.3≤
ρ≤1.2

cm, the SNR can be as high as 100, with a photon counting superior to 500

kHz. For brain human experiments, on the other hand, large source–detector distances are desirable to separate cortical responses from scalp and skull responses. Since the mean photon depth sensitivity is approximately one-third to one-half of the distance between a source and a detector [
55], separations of 2.5

cm or more on the surface of the human head are needed to probe the cerebral cortex. These large separations limit the SNR for a
single detection fibre to vary from 2 to 10 in most cases (i.e. corresponding to photon counting rates of 10–100

kHz). In these cases, by averaging over many trials and/or a population sample, or by averaging over many detection fibres, it is possible to further improve measurement SNR and derive meaningful results in the human brain.
Before moving to the validation section, we briefly consider the current state of the field in relation to practical application. The ability to measure tissue haemodynamics and haemodynamic responses to stimuli is important for many clinical and pre-clinical problems, including brain pathology and tumour detection/characterization. Diffuse optical tomographic (DOT) and spectroscopic (DOS/NIRS) methods have been demonstrated to measure tissue blood volume, blood oxygenation and changes thereof, in both research and clinical settings. In some cases, one can obtain information about blood flow with DOS, but this information is derived indirectly [
56,
57]. The development of DCS now enables clinicians to measure several haemodynamic parameters independently with non-invasive optical probes (i.e. haemoglobin concentrations by DOS/NIRS and
blood flow by DCS). This development opens up the possibility for monitoring
oxygen metabolism. Furthermore, even without the benefit of DOS/NIRS, DCS can provide important information about microvascular blood flow that is often of interest in its own right. Translation of DCS methods into the clinic holds potential for spectacular future pay-offs. Thus, although our microscopic understanding of tissue DCS signals is incomplete, it remains worthwhile to push forward to discover the physiological scenarios, wherein DCS can be used fruitfully.